Microbiome Translating innovation Program

We now know that interactions between microorganisms that live on and inside our bodies can interact with our genes, and are affected by the environment we live in, our lifestyle and the dietary choices we make.

These interactions can contribute to the onset and progression of many diseases including functional gastrointestinal disorders, inflammatory bowel diseases, liver and associated metabolic diseases and cancers.

If we can expand on this knowledge, and harness it in a targeted way, this may present new opportunities for improved diagnosis, prevention and treatment of various chronic diseases.

To meet the strong need to expand our knowledge of the human microbiome in health and disease, the Microbiome Translating Innovation Program has been established at TRI.

More details on this Program will be available in the coming months.